latest news

Epics Therapeutics raises €7.2M for its drug discovery program

EPICS Therapeutics is a newly created spin-off company of ULB dedicated to develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics. We are delighted to welcome them in our incubator. Discover the official press release here.